KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 129 filers reported holding KEROS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $527,645 | +17.9% | 16,551 | +48.5% | 0.00% | – |
Q2 2023 | $447,685 | +0.4% | 11,142 | +6.7% | 0.00% | – |
Q1 2023 | $445,874 | +18.6% | 10,442 | +33.4% | 0.00% | – |
Q4 2022 | $375,853 | +24.0% | 7,827 | -2.8% | 0.00% | – |
Q3 2022 | $303,000 | -20.1% | 8,056 | +15.4% | 0.00% | – |
Q1 2022 | $379,000 | -6.7% | 6,980 | +0.6% | 0.00% | – |
Q4 2021 | $406,000 | +34.9% | 6,937 | -9.0% | 0.00% | – |
Q3 2021 | $301,000 | -90.6% | 7,627 | -89.9% | 0.00% | -100.0% |
Q2 2021 | $3,206,000 | -72.8% | 75,504 | -60.6% | 0.00% | -66.7% |
Q1 2021 | $11,783,000 | -12.0% | 191,423 | +0.9% | 0.00% | -25.0% |
Q4 2020 | $13,383,000 | +84.5% | 189,719 | +0.9% | 0.00% | +100.0% |
Q3 2020 | $7,254,000 | -35.9% | 188,082 | -37.7% | 0.00% | -50.0% |
Q2 2020 | $11,322,000 | – | 301,825 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
Atom Investors LP | 49,981 | $3,526,000 | 0.36% |